Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phAQP3 (#RDB07311)

Promoter collection, Human AQP3 promoter

Alternative name U2663 (2041)-8
Clone info. PCR amplified human AQP3 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 33448723 to 33447505 (NC_000009.12); relatively -1090 to +129, where +1 corresponds to 1nt of NM_004925.4.
Comment PCR cloning, forward primer: ggtgaatccccatctccact; reverse primer: gacaccagctccttctgtcg. Entire sequence of promoter region has not been confirmed.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human aquaporin 3 (Gill blood group) genomic DNA
Depositor|Developer DNA Bank, | Pan, Jianzhi |
 
Remarks, protocol and/or map (pdf) RDB07311.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07311 pGL4-phAQP3 DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phAQP3 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07311).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07311_A6Bmp1-2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pGL4-4174F ()
Sequence file: RDB07311_A6Bma.seq check
>07311_07311_A6Bm_1_pGL4-4174F_A02_02.ab1
    1 ACGAGGGTCA GACATTTCTC TGGCCTAACT GGCCGGTACC GTGTTGCTAG CCTCGAGGAT
   61 GGTGAATCCC CATCTCCACT AAAAAAACAA AAATTAGCTG GGCATGGTGG TGTGCACCTG
  121 TAATCCCAGC TAATCGGGAG GCTGAAGCAG GAGAATCACT TGAACCTGGG AGGTGGAGGT
  181 TGCAGGGAGC CGAGATCACG CCATTGCACT CCACCTAGGC GACAGAGAGA GACTCCGTCT
  241 AAAAAAAAAA AAGAGACAGA CTCTTCCTTG GCTGGGGGTA AGTCAGATGG GAGAGGAGAG
  301 GGTTAAAAAC AGCTGGGACT CAGCCTGCTG GCAAACATGT GGCATGTGGC ATGTCGGGGC
  361 AACTGCAGCT CAGCCTCTGG AGCCATGTGA GCAATGCACG CAGGTACACG TGTGACAAGC
  421 TAGGTCACCT AGCCATGTTC AACAGGCATG TGCACAGCCA CGAGGAATGC CCAGCCGTAC
  481 AATTAGGCAC ACAGGACATC CGCCATGTGT AGACACAGCT GTGGACATAG CTGGCCAGGA
  541 CATGCGACAC ACGACGTGCT CATAGCACAG GGAGAAGGGC CCATGAAGTC TGGTTGGAAC
  601 TCAGCACGTG TGTCTGTGTG CCCACCTGAG TCTGGACTGC TGCCCCTCTG ACACTAGCTG
  661 TCCCCTTGAA GGGTCGGTGC CTTATCTGTC CTGACAGAAG AGACAGTGTT GCTTCTCACT
  721 TGGGGCTCGC AGCCTCCTCC TCCTGCCTCG AACTGAGGAT CTGTTGGGTC CAGTCATCCT
  781 GGAGAGATGC GGCCAGTTTC TTTCTGACAG GTCTCCTCCT GCCCGCAAGG AAGTGGGGTG
  841 ATCACAGGGC GCAGTGGTCT CTATGACAGC TGCATCCTCT CCAGCCATGG CCCTGAACCC
  901 TGCCTATATC CCACCATTGG CTCTCAGATC TGCCTAAGCC TCTCAGCCCC CTTGACGTCC
  961 CCCTCCCTTA AGCGCCCTCC GAAGCCACCC GTCCCTCAAA GCTCCTCACA CTTCATGCCC
 1021 GCAGCTCCTC CACCCGGCGT CCGCACAAGC TCCAGCGAAG TGGGGCCGGG GGCAAGGGGC
 1081 CGCCACTCCT CGGCGCTCGA CTGCAGTCGA CTGCAGCGGC GCCCAGTGTA TCTCCAGCAC
1141 CTACATTA
//
Primer: pGL4-136R ()
Sequence file: RDB07311_A6Bmb.seq check
>07311_07311_A6Bm_1_pGL4-136R_B02_05.ab1
    1 AGCTTTAGGT TTTGGCATCT TCCATGGTGG CTTTACCAAC AGTACCGGAT TGCCAAGCTT
   61 GGCCGCCGAG GCCAGATCTT GATGACACCA GCTCCTTCTG TCGACCCATG GCGGGGCAGG
  121 CGGCGGCGCT GTCGGGCGGG CAGGGGTGGC GGGAGGCGGT GGCGCAGCGA GCAGCGGCCT
  181 CCAGCGCTGG TGGCTCCCTT TATAGGAGCG CTGGAGACAC GGGCCCCGCC CGCCCTGCAG
  241 CCCCGCCCTG CAGTCCCGGA GCGCCGAGGA GTGCGCGCCC CCTCGCCCCC GCCCCACCTC
  301 GGCTGGGAGG CTGGTGCGGA CGCCGGGTGG AGGGAGCTGC GGGCATGGAG TGTGAGGAGC
  361 TTTGAGGGAC GGGTGGCCTT CGGAGGGCGC TTAAGGGAGG GGACGTCAAG GGGGCTGAGA
  421 GGCTTAGGCA GATCTGAGAG CCAATGGTGG GATTATAGGC AGGGTTCAGG GCCATGGCTG
  481 GAGAGGATGC AGCTGTCATA GAGACCACCT GCGCCCTGTG ATCACCCCAC TTCCTTGCGG
  541 GCAGGAGGAG ACCTGTCAGA AAGAAACTGG CCGCATCTCT CCAGGATGAC TGGACCCAAC
  601 AGATCCTCAG TTCGAGGCAG GAGGAGGAGG CTGCGAGCCC CAAGTGAGAA GCAACACTGT
  661 CTCTTCTGTC AGGACAGATA AGGCACCGAC CCTTCAAGGG GACAGCTAGT GTCAGAGGGG
  721 CAGCAGTCCA GACTCAGGTG GGCACACAGA CACACGTGCT GAGTTCCAAC CAGACTTCAT
  781 GGGCCCTTCT CCCTGTGCTA TGAGCACGTC GTGTGTCGCA TGTCCTGGCC AGCTATGTCC
  841 ACAGCTGTGT CTACACATGG CGGATGTCCT GTGTGCCTAA TTGTACGGCT GGGCATTCCT
  901 CGTGGCCTGT GCACATGCCT GTTGAACATG GCTAGGTGAC CTAGCTTGTC ACACGTGTAC
  961 CTTGCGTGCA TTGCTCACAT GGCCTCCAGA GGCTGAGCTG CAGTTTGCCC CGACATGCCA
 1021 CATGCCACAT GTTTTGCCAG CAGCTGAGTC CCAGCTTGTT TTTTACCCTC TTCCTTCTCC
 1081 CATCTTGACT TAACCCCCAA GCCAGAGAGT CGTCCTTTTT TTTTTTTAGA CGGGAATCTC
1141 TCCCGATCGC CTTAAGGTGG AATGC
//
Primer: pAxCALNL_F1 ()
Sequence file: RDB07311_A6Bmc.seq check
>07311_07311_A6Bm_1_pAxCALNL_F1_C02_08.ab1
    1 ATCAATTGTT TTCTTTATCA TGTCTGCTCG AAGCGGCCGG CCGCCCCGAC TCTAAGGAAT
   61 TATTACACGG CGATCTTGCC GCCCTTCTTG GCCTTAATGA GAATCTCGCG GATCTTGCGG
  121 GCGTCCAACT TGCCGGTCAG TCCTTTAGGC ACCTCGTCCA CGAACACAAC ACCACCGCGC
  181 AGCTTCTTGG CGGTTGTAAC CTGGCTGGCC ACATAGTCCA CGATCTCCTT CTCGGTCATG
  241 GTTTTACCGT GTTCCAGCAC GACGACTGCG GCGGGCAGCT CGCCGGCATC GTCGTCGGGC
  301 AGGCCGGCGA CCCCGGCGTC GAAGATGTTG GGGTGTTGCA GCAGGATGCT CTCCAGTTCG
  361 GCTGGGGCTA CCTGGTAGCC CTTGTATTTG ATCAGGCTCT TCAGCCGGTC CACGATGAAG
  421 AAGTGCTCGT CCTCGTCCCA GTAGGCGATG TCGCCGCTGT GCAGCCAGCC GTCCTTGTCG
  481 ATGAGAGCGT TTGTAGCCTC GGGGTTGTTA ACGTAGCCGC TCATGATCAT GGGGCCACGG
  541 ACGCACAGCT CGCCGCGCTG GTTCACACCC AGTGTCTTAC CGGTGTCCAA GTCCACCACC
  601 TTAGCCTCGA AGAAGGGCAC CACCTTGCCT ACTGCGCCAG GCTTGTCGTC CCCTTCGGGG
  661 GTGATCAGAA TGGCGCTGGT TGTTTCTGTC AGGCCGTAGC CCTGGCGGAT GCCTGGTAAG
  721 TGGAAGCGTT TGGCCACGGC CTCACCTACC TCCTTGCTGA GCGGCGCCCC GCCGCTGGGC
  781 GATCTCGTGC AAGTTGCTTA GGTCGTACTT GTCGATGAGA GTGCTCTTAG CGAAGAAGCT
  841 AAATAGTGTG GGCACCAGCA GGGCCAGATT GAATCTTATA GTCTTGCAAG CTGCGCAGGA
  901 ATAAGCTCCT CCTCGAAGCG GTACATGAGC ACGACCCGAA AGCCGCAGAT CAAGTAGCCC
  961 AACGGTGGTT GACATGCCGA AAGCCTTGGT TGAAATGGCA CCCACGCCTG AGAATAGCCG
 1021 TTGTCCGGAA TGATTCTGGT TGCCCGAAAA TGGGGGTCGC CCGGCCATGA CTGAAATCCG
 1081 ACACCAAGCC CGTGTCGGGT GCGGTAAGCT TAGCCCCTTG GCAATTCGTA CTGCCACTTC
1141 TGTTCCTTGA ATCAGGCCGT ATGGTTTGTT CCCCGGCTCG CTAAGAGCT
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles